Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
193.93B
Market cap193.93B
Price-Earnings ratio
29.57
Price-Earnings ratio29.57
Dividend yield
2.18%
Dividend yield2.18%
Average volume
8.79M
Average volume8.79M
High today
$111.72
High today$111.72
Low today
$109.10
Low today$109.10
Open price
$110.11
Open price$110.11
Volume
1.63M
Volume1.63M
52 Week high
$139.06
52 Week high$139.06
52 Week low
$105.27
52 Week low$105.27

Stock Snapshot

The current Abbott(ABT) stock price is $111.60, with a market capitalization of 193.93B. The stock trades at a price-to-earnings (P/E) ratio of 29.57 and offers a dividend yield of 2.2%.

On 2026-03-17, Abbott(ABT) stock traded between a low of $109.10 and a high of $111.72. Shares are currently priced at $111.60, which is +2.3% above the low and -0.1% below the high.

The Abbott(ABT)'s current trading volume is 1.63M, compared to an average daily volume of 8.79M.

In the last year, Abbott(ABT) shares hit a 52-week high of $139.06 and a 52-week low of $105.27.

In the last year, Abbott(ABT) shares hit a 52-week high of $139.06 and a 52-week low of $105.27.

ABT News

Simply Wall St 12h
Assessing Abbott Laboratories Valuation After Recent Share Price Weakness and Modest Undervaluation Estimate

Advertisement Event context and recent performance Abbott Laboratories (ABT) has been drawing investor attention after a period where the stock has delivered...

Assessing Abbott Laboratories Valuation After Recent Share Price Weakness and Modest Undervaluation Estimate
TipRanks 5d
Abbott announces results from FreeDM2 randomized controlled trial

Abbott (ABT) announced results from the FreeDM2 randomized controlled trial showing that people using FreeStyle Libre continuous glucose monitoring technology h...

Simply Wall St 5d
Abbott’s Freedom To Work Plan And What It May Mean For NYSE ABT

Abbott Laboratories has rolled out a phased retirement program called "Freedom to Work" for long tenured employees aged 55 and older. The program allows partic...

Abbott’s Freedom To Work Plan And What It May Mean For NYSE ABT

Analyst ratings

71%

of 31 ratings
Buy
71%
Hold
29%
Sell
0%

More ABT News

Nasdaq 6d
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever

Success in business is challenging. Most new ventures don't last more than a decade. A few select companies survive and thrive for several decades. Fewer still...

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.